| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.26M | 7.55M | 7.85M | 7.25M | 8.64M | 12.12M |
| Gross Profit | 2.15M | 4.82M | 4.97M | 4.99M | 5.72M | 7.99M |
| EBITDA | 1.67M | 4.16M | -3.56M | 3.12M | 7.50M | -2.99M |
| Net Income | 2.27M | 2.14M | -4.58M | 1.92M | 6.78M | -7.45M |
Balance Sheet | ||||||
| Total Assets | 68.45M | 78.71M | 75.81M | 83.48M | 76.98M | 81.28M |
| Cash, Cash Equivalents and Short-Term Investments | 3.29M | 4.82M | 4.63M | 7.65M | 6.42M | 16.24M |
| Total Debt | 9.39M | 9.45M | 10.59M | 13.37M | 15.03M | 35.78M |
| Total Liabilities | 19.10M | 31.39M | 34.88M | 38.01M | 33.99M | 44.29M |
| Stockholders Equity | 47.03M | 45.09M | 38.98M | 43.44M | 42.77M | 36.79M |
Cash Flow | ||||||
| Free Cash Flow | 443.00K | -582.00K | -1.30M | 2.45M | -3.12M | 38.43M |
| Operating Cash Flow | 444.00K | 856.00K | 398.00K | 3.48M | -1.44M | 38.73M |
| Investing Cash Flow | -1.45M | -77.00K | -840.00K | 2.76M | -4.28M | 1.05M |
| Financing Cash Flow | -1.94M | -575.00K | -2.66M | -5.09M | -4.08M | -30.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £50.18M | 3.28 | 6.10% | 3.92% | -6.10% | 889.93% | |
70 Outperform | £22.92M | 5.00 | 5.05% | ― | -7.14% | ― | |
69 Neutral | £27.29M | 19.57 | 4.44% | 0.91% | -2.80% | 30.05% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
52 Neutral | £34.23M | -0.40 | -11.20% | ― | 15.55% | -116.52% | |
51 Neutral | £155.65M | -6.51 | -9.62% | ― | ― | ― | |
42 Neutral | £39.80M | 28.06 | ― | ― | ― | ― |